Patents by Inventor Baptiste Bessiere

Baptiste Bessiere has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHALABLE GASEOUS MIXTURE FOR TREATING CHRONIC PAIN IN PATENTS RECEIVING DRUGS FROM MULTIPLE THERAPEUTIC CLASSES
    Publication number: 20220313727
    Abstract: The invention relates to a gaseous mixture containing 50% of nitrous oxide (N2O) and at least 20% of oxygen (O2) (mol %) for use as an inhalable medicament for treating chronic pain in a human patient treated with a plurality of drug substances of at least two different therapeutic classes.
    Type: Application
    Filed: October 10, 2019
    Publication date: October 6, 2022
    Inventors: Laurent LECOURT, Baptiste BESSIERE, Patrick HOUETO, Céclle DELVAL, Juan Ferando RAMIREZ
  • Use of xenon for treating hypersensitivity to pain
    Patent number: 8632821
    Abstract: The invention relates to a gaseous mixture containing oxygen (O2) and a volume proportion of 20 to 70% of xenon (Xe) for use as an inhalable drug for preventing or treating hypersensitivity to pain in humans or animals, in particular hypersensitivity to pain expressed as hyperalgesia or allodynia.
    Type: Grant
    Filed: July 13, 2010
    Date of Patent: January 21, 2014
    Assignees: L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude, Université Bordeaux Segalen
    Inventors: Baptiste Bessiere, Guy Simonnet
  • XENON-BASED INHALABLE DRUG FOR PREVENTING ADDICTION RELAPSES IN HUMANS
    Publication number: 20130071487
    Abstract: The invention relates to a gas composition containing xenon gas for use in preventing the relapse of a patient who has been weaned from at least one psychotropic product which resulted in said patient becoming habituated, the xenon being administered to the patient by inhalation. The composition of the invention contains an effective volume proportion of xenon, in particular from 5 to 70% by volume of xenon. DRAWING: FIG.
    Type: Application
    Filed: May 9, 2011
    Publication date: March 21, 2013
    Applicant: L'Air Liquide, Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude
    Inventors: Baptiste Bessiere, Jan Pype
  • XENON-BASED INHALABLE DRUG FOR TREATING OR PREVENTING INDUCED DYSKINESIA
    Publication number: 20120213860
    Abstract: The invention relates to the use of a gaseous drug based on gaseous xenon for inhalation for treating or preventing in mammals dyskinesia induced by a dopaminergic agonist. The invention is particularly useful for treating levodopa induced dyskinesia in patients being treated for Parkinson's disease.
    Type: Application
    Filed: November 3, 2010
    Publication date: August 23, 2012
    Applicant: L'Air Liquide Societe Anonyme Pour L'Etude Et L'Exploitation Des Procedes Georges Claude
    Inventor: Baptiste Bessiere
  • USE OF XENON FOR TREATING HYPERSENSITIVITY TO PAIN
    Publication number: 20120128789
    Abstract: The invention relates to a gaseous mixture containing oxygen (O2) and a volume proportion of 20 to 70% of xenon (Xe) for use as an inhalable drug for preventing or treating hypersensitivity to pain in humans or animals, in particular hypersensitivity to pain expressed as hyperalgesia or allodynia.
    Type: Application
    Filed: July 13, 2010
    Publication date: May 24, 2012
    Applicants: Universite Bordeau Segalen, L'Air Liquide Societe Anonyme Pour L'Etude Et Exploitation Des Procedes georges Claude
    Inventors: Baptiste Bessiere, Guy Simonnet